Re: Kuang et al.: Estimating lead timegained by optical coherence tomographyin detecting glaucoma beforedevelopment of visual field defects(Ophthalmology 2015;122:2002-9)
Alfred Sommer Correspondence | Reply Re: Boyer et al.: Outcomes with as-needed ranibizumab after initialmonthly therapy: long-term outcomesof the phase III RIDE and RISE trials(Ophthalmology. 2015;122:2504-13) Brijesh TakkarShorya Azad Correspondence Re: McCannel: Simulation surgicalteaching in ophthalmology(Ophthalmology 2015;122:2371-2) Chryssa McAlister Correspondence | Reply Re: Chia et al.: Five-year clinical trialon atropine for the treatment ofmyopia 2: myopia control withatropine 0.01% eyedrops(Ophthalmology 2016;123:391-9) Virgilio Galvis et al. Correspondence | Reply RE: Campochiaro et al.: Scatterphotocoagulation does not reducemacular edema or treatment burdenin patients with retinal vein occlusion(Ophthalmology 2014;121:209-19) Brijesh TakkarShorya Azad Correspondence | Reply Re: Wang et al.: Acute peripapillaryretinal pigment epithelium changesassociated with acute intraocularpressure elevation(Ophthalmology 2015,122:2022-8) Gema RebolledaJavier Garca-MontesinosFrancisco Jos Muoz-NegreteJulio Jos Gonzlez-Lpez Correspondence | Reply Re: Freitas-Neto et al.: Increasedsubmacular choroidal thickness inactive, isolated, extramaculartoxoplasmosis(Ophthalmology 2016;123:222-4) Philemon HuangRupesh Agrawal Correspondence | Reply |Reply http://www.aaojournal.org/article/S0161-6420(16)00333-X/abstract?rss=yes
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2017
Categories |